迪普科技：10月23日召开董事会会议

Group 1 - The core point of the article is that Dipu Technology (SZ 300768) held its 11th meeting of the third board on October 23, 2025, to review the proposal for the company's Q3 2025 report [1] - For the first half of 2025, Dipu Technology's revenue composition is as follows: 28.58% from operators, 24.9% from other businesses, 16.65% from government, 15.64% from public utilities, and 14.24% from finance [1] - As of the report date, Dipu Technology has a market capitalization of 14.9 billion yuan [1] Group 2 - The article mentions that Chinese innovative drugs have generated $80 billion in overseas licensing this year, indicating a hot secondary market in biomedicine [1] - The conversation with Lu Gang, a partner at Chuangdongfang Investment, highlights the contrast between the booming secondary market and the cooling fundraising environment in the primary market [1]